Home About us Contact
|
Home About us Contact | ||
|
|
||
Amorphous Form (amorphous + form)
Selected AbstractsChemInform Abstract: Li+ Diffusion and Its Structural Basis in the Nanocrystalline and Amorphous Forms of Two-Dimensionally Ion-Conducting LixTiS2.CHEMINFORM, Issue 40 2001Rudolf Winter Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a "Full Text" option. The original article is trackable via the "References" option. [source] The structure and dynamic properties of nitrile,butadiene rubber/poly(vinyl chloride)/hindered phenol crosslinked compositesJOURNAL OF APPLIED POLYMER SCIENCE, Issue 1 2008Ping Xiang Abstract In this article, a new nitrile,butadiene rubber (NBR) crosslinked composites containing poly(viny chloride) (PVC) and hindered phenol (AO-80 and AO-60) was successfully prepared by melt-blending procedure. Microstruture and dynamic mechanical properties of the composites were investigated using SEM, DSC, XRD, and DMTA. Most of hindered phenol was dissolved in the NBR/PVC matrix and formed a much fine dispersion. The results of DSC and DMTA showed that strong intermolecular interaction was formed between the hindered phenol and NBR/PVC matrix. The NBR/PVC/AO-80 crosslinked composites showed only one transition with higher glass transition temperature and higher tan , value than the neat matrix, whereas for the NBR/PVC/AO-60 crosslinked composites, a new transition appeared above the glass transition temperature of matrix, which was associated with the intermolecular interaction between AO-60 and PVC component of the matrix. Both AO-80 and AO-60 in the crosslinked composites existed in amorphous form. Furthermore, the chemical crosslinking of composites resulted in better properties of the materials, e.g., considerable tensile strength and applied elastic reversion. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2008 [source] Drug,polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion developmentJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 7 2010Feng Qian Abstract Drug,polymer solid dispersion has been demonstrated as a feasible approach to formulate poorly water-soluble drugs in the amorphous form, for the enhancement of dissolution rate and bioperformance. The solubility (for crystalline drug) and miscibility (for amorphous drug) in the polymer are directly related to the stabilization of amorphous drug against crystallization. Therefore, it is important for pharmaceutical scientists to rationally assess solubility and miscibility in order to select the optimal formulation (e.g., polymer type, drug loading, etc.) and recommend storage conditions, with respect to maximizing the physical stability. This commentary attempts to discuss the concepts and implications of the drug,polymer solubility and miscibility on the stabilization of solid dispersions, review recent literatures, and propose some practical strategies for the evaluation and development of such systems utilizing a working diagram. © 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:2941,2947, 2010 [source] Process induced disorder in crystalline materials: Differentiating defective crystals from the amorphous form of griseofulvinJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 8 2008Tao Feng Abstract This research investigates milling induced disorder in crystalline griseofulvin. Griseofulvin was subjected to cryogenic milling for various lengths of time. For comparison, the amorphous form of griseofulvin was also prepared by the quench melt method. Different analytical techniques were used to study the differences between the cryomilled, amorphous and crystalline forms of the drug. Cryogenic milling of griseofulvin progressively reduces the crystallinity of the drug by inducing crystal defects, rather than amorphous materials. Raman analysis provides evidence of structural differences between the two. The differences between the defective crystals produced by milling and the amorphous form are significant enough as to be measurable in their bulk thermal properties. Defective crystals show significant decrease in the heat of fusion as a function of milling time but do not exhibit a glass transition nor recrystallization from the amorphous form. Crystal defects undergo recrystallization upon heating at temperatures well below the glass transition temperature (Tg) in a process that is separate and completely independent from the crystallization of the amorphous griseofulvin, observed above Tg. Physical mixtures of defective crystals and amorphous drug demonstrate that the thermal events associated with each form persist in the mixtures, unaffected by the presence of the other form. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97: 3207,3221, 2008 [source] Effect of characteristics of compounds on maintenance of an amorphous state in solid dispersion with crospovidoneJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 6 2007Yusuke Shibata Abstract Solid dispersion (SD) of indomethacin with crospovidone (CrosPVP) shows useful characteristics for preparation of dosage forms. This study aimed to determine the types of drugs that could adopt a stable amorphous form in SD. Twenty compounds with various melting points (70,218°C), molecular weights (135,504) and functional groups (amide, amino, carbonyl, hydroxyl, ketone etc.) were prepared in SD with CrosPVP. The CrosPVP SDs were prepared using a mechanical mixing and heating method. Melting point and molecular weight were found to have no influence on the ability of a compound to maintain an amorphous state in SD. All compounds containing hydrogen-bond-donor functional groups existed in an amorphous state in SD for at least 6 months. Infrared spectra suggested an interaction between the functional groups of these compounds and amide carbonyl group of CrosPVP. Compounds without hydrogen-bond-donor groups could not maintain an amorphous state and underwent recrystallization within 1 month. It was suggested that the presence of a hydrogen-bond-donor functional group in a compound is an important factor affecting the stable formation of SD with CrosPVP, which contains a hydrogen-bond acceptor. © 2006 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96:1537,1547, 2007 [source] Structural determination of the stable and meta-stable forms of atomoxetine HCl using single crystal and powder X-ray diffraction methodsJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 8 2006Gregory A. Stephenson Abstract StratteraÔ is the first FDA-approved nonstimulant medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents, and adults. Two polymorphic forms and an amorphous form of the active pharmaceutical ingredient, atomoxetine HCl, were discovered during drug development. The thermodynamically stable polymorphic form was selected for the commercial product. The stable form readily grows as crystals suitable for single crystal diffraction. The meta-stable crystal form is isolated by rapid crystallization, providing crystals that are too small for routine single crystal methods; consequently its structure was determined by X-ray powder diffraction. © 2006 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 95: 1677,1683, 2006 [source] Ultrasound-compacted indomethacin/polyvinylpyrrolidone systems: Effect of compaction process on particle morphology and dissolution behaviorJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 8 2002Adamo Fini Abstract Indomethacin (IMC)/polyvinylpyrrolidone systems were prepared under different technological conditions, using co-evaporation, kneading, traditional, and ultrasound (US) compaction. The materials thus obtained were milled and sieved and the powders were analyzed by using scanning electron microscopy to evaluate the morphology of the final particles and the fractal dimension of the particle contour. In the case of US-treated particles, scanning electron micrographs suggest that IMC could have partially covered the excipient granule surface, which appears lustrous and smooth, whereas after co-evaporation, the particles display a stratified structure. The external color of the granules, the hot stage microscopy examination, and the absence of the melting peak of the drug in thermograms supports the idea that IMC converts into an amorphous form under US discharge. Each technological treatment performed on the binary mixtures increases the dissolution rate of the drug, with respect to the pure drug and the physical mixture, but to a lesser extent than US compaction. US compaction and co-evaporation produce comparable results in improving the release of the drug. Polyvinylpyrrolidone offers better results than ,-cyclodextrin in promoting the dissolution of IMC, when both systems are compacted under US. © 2002 Wiley-Liss Inc. and the American Pharmaceutical Association J Pharm Sci 91:1880,1890, 2002 [source] Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion techniqueJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 9 2008Vikram R. Shinde ABSTRACT The solid-state properties and dissolution behaviour of lamotrigine in its inclusion complex with ,-cyclodextrin (,CD) and solid dispersions with polyvinylpyrrolidone K30 (PVP K30) and polyethyl-eneglycol 6000 were investigated. The phase solubility profile of lamotrigine with ,CD was classified as AL -type, indicating formation of a 1:1 stoichiometry inclusion complex, with a stability constant of 369.96 ± 2.26 M,1. Solvent evaporation and kneading methods were used to prepare solid dispersions and inclusion complexes, respectively. The interaction of lamotrigine with these hydrophilic carriers was evaluated by powder X-ray diffractometry, Fourier transform infrared spectroscopy and differential scanning calorimetry. These studies revealed that the drug was no longer present in crystalline state but was converted to an amorphous form. Among the binary systems tested, PVP K30 (1:5) showed greatest enhancement of the solubility and dissolution of lamotrigine. [source] Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMRMAGNETIC RESONANCE IN CHEMISTRY, Issue 11 2005David C. Apperley Abstract We have characterised the stable polymorphic forms of two drug molecules, indomethacin (1) and nifedipine (2) by 13C CPMAS NMR and the resonances have been assigned. The signal for the CCl carbon of indomethacin has been studied as a function of applied magnetic field, and the observed bandshapes have been simulated. Variable-temperature 1H relaxation measurements of static samples have revealed a T1, minimum for indomethacin at 17.8 °C. The associated activation energy is 38 kJ mol,1. The relevant motion is probably an internal rotation and it is suggested that this involves the COCH3 group. Since the two drug compounds are potential candidates for formulation in the amorphous state, we have examined quench-cooled melts in detail by variable-temperature 13C and 1H NMR. There is a change in slope for and at the glass transition temperature (Tg) for indomethacin, but this occurs a few degrees below Tg for nifedipine, which is perhaps relevant to the lower real-time stability of the amorphous form for the latter compound. Comparison of relaxation time data for the crystalline and amorphous forms of each compound reveals a greater difference for nifedipine than for indomethacin, which again probably relates to real-time stabilities. Recrystallisation of the two drugs has been followed by proton bandshape measurements at higher temperatures. It is shown that, under the conditions of the experiments, recrystallisation of nifedipine can be detected already at 70 °C, whereas this does not occur until 110 °C for indomethacin. The effect of crushing the amorphous samples has been studied by 13C NMR; nifedipine recrystallises but indomethacin does not. The results were supported by DSC, powder XRD, FTIR and solution-state NMR measurements. Copyright © 2005 John Wiley & Sons, Ltd. [source] Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopyJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 12 2005Thomas J. Offerdahl Abstract Although most drugs are formulated in the crystalline state, amorphous or other crystalline forms are often generated during the formulation process. The presence of other forms can dramatically affect the physical and chemical stability of the drug. The identification and quantitation of different forms of a drug is a significant analytical challenge, especially in a formulated product. The ability of solid-state 13C NMR spectroscopy with cross polarization (CP) and magic-angle spinning (MAS) to quantify the amounts of three of the multiple crystalline and amorphous forms of the artificial sweetener neotame is described. It was possible to quantify, in a mixture of two anhydrous polymorphic forms of neotame, the amount of each polymorph within 1,2%. In mixtures of amorphous and crystalline forms of neotame, the amorphous content could be determined within 5%. It was found that the crystalline standards that were used to prepare the mixtures were not pure crystalline forms, but rather a mixture of crystalline and amorphous forms. The effect of amorphous content in the crystalline standards on the overall quantitation of the two crystalline polymorphic forms is discussed. The importance of differences in relaxation parameters and CP efficiencies on quantifying mixtures of different forms using solid-state NMR spectroscopy is also addressed. © 2005 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 94:2591,2605, 2005 [source] Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopyJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue 8 2009Andrea Heinz Abstract Objectives Solid-state transformations may occur during any stage of pharmaceutical processing and upon storage of a solid dosage form. Early detection and quantification of these transformations during the manufacture of solid dosage forms is important since the physical form of an active pharmaceutical ingredient can significantly influence its processing behaviour, including powder flow and compressibility, and biopharmaceutical properties such as solubility, dissolution rate and bioavailability. Key findings Vibrational spectroscopic techniques such as infrared, near-infrared, Raman and, most recently, terahertz pulsed spectroscopy have become popular for solidstate analysis since they are fast and non-destructive and allow solid-state changes to be probed at the molecular level. In particular, Raman and near-infrared spectroscopy, which require no sample preparation, are now commonly used coupled to fibreoptic probes and are able to characterise solid-state conversions in-line. Traditionally, uni- or bivariate approaches have been used to analyse spectroscopic data sets; however, recently the simultaneous detection of several solid-state forms has been increasingly performed using multivariate approaches where even overlapping spectral bands can be analysed. Summary This review discusses the applications of different vibrational spectroscopic techniques to detect and monitor solid-state transformations possible for crystalline polymorphs, hydrates and amorphous forms of pharmaceutical compounds. In this context, the theoretical basis of solid-state transformations and vibrational spectroscopy and common experimental approaches are described, including recent methods of data analysis. [source] Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMRMAGNETIC RESONANCE IN CHEMISTRY, Issue 11 2005David C. Apperley Abstract We have characterised the stable polymorphic forms of two drug molecules, indomethacin (1) and nifedipine (2) by 13C CPMAS NMR and the resonances have been assigned. The signal for the CCl carbon of indomethacin has been studied as a function of applied magnetic field, and the observed bandshapes have been simulated. Variable-temperature 1H relaxation measurements of static samples have revealed a T1, minimum for indomethacin at 17.8 °C. The associated activation energy is 38 kJ mol,1. The relevant motion is probably an internal rotation and it is suggested that this involves the COCH3 group. Since the two drug compounds are potential candidates for formulation in the amorphous state, we have examined quench-cooled melts in detail by variable-temperature 13C and 1H NMR. There is a change in slope for and at the glass transition temperature (Tg) for indomethacin, but this occurs a few degrees below Tg for nifedipine, which is perhaps relevant to the lower real-time stability of the amorphous form for the latter compound. Comparison of relaxation time data for the crystalline and amorphous forms of each compound reveals a greater difference for nifedipine than for indomethacin, which again probably relates to real-time stabilities. Recrystallisation of the two drugs has been followed by proton bandshape measurements at higher temperatures. It is shown that, under the conditions of the experiments, recrystallisation of nifedipine can be detected already at 70 °C, whereas this does not occur until 110 °C for indomethacin. The effect of crushing the amorphous samples has been studied by 13C NMR; nifedipine recrystallises but indomethacin does not. The results were supported by DSC, powder XRD, FTIR and solution-state NMR measurements. Copyright © 2005 John Wiley & Sons, Ltd. [source] | ||||||||||